453 related articles for article (PubMed ID: 23829186)
1. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
[No Abstract] [Full Text] [Related]
3. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two polymorphs of lornoxicam.
Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
[TBL] [Abstract][Full Text] [Related]
5. Cocrystals of acyclovir with promising physicochemical properties.
Sarkar A; Rohani S
J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
[TBL] [Abstract][Full Text] [Related]
6. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Kumar S; Gupta A; Prasad R; Singh S
Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
[TBL] [Abstract][Full Text] [Related]
7. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
[TBL] [Abstract][Full Text] [Related]
8. Novel furosemide cocrystals and selection of high solubility drug forms.
Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
[TBL] [Abstract][Full Text] [Related]
9. Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.
Panzade P; Shendarkar G
Turk J Pharm Sci; 2019 Sep; 16(3):310-316. PubMed ID: 32454729
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol cocrystals with enhanced solubility and tabletability.
Zhou Z; Li W; Sun WJ; Lu T; Tong HHY; Sun CC; Zheng Y
Int J Pharm; 2016 Jul; 509(1-2):391-399. PubMed ID: 27282539
[TBL] [Abstract][Full Text] [Related]
11. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
Ober CA; Gupta RB
AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
[TBL] [Abstract][Full Text] [Related]
12. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z
Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368
[TBL] [Abstract][Full Text] [Related]
13. Chrysin cocrystals: Characterization and evaluation.
Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization and dissolution profile of mycophenolic acid cocrystals.
Zeng QZ; Ouyang J; Zhang S; Zhang L
Eur J Pharm Sci; 2017 May; 102():140-146. PubMed ID: 28254392
[TBL] [Abstract][Full Text] [Related]
15. Cocrystal screening of hydroxybenzamides with benzoic acid derivatives: a comparative study of thermal and solution-based methods.
Manin AN; Voronin AP; Drozd KV; Manin NG; Bauer-Brandl A; Perlovich GL
Eur J Pharm Sci; 2014 Dec; 65():56-64. PubMed ID: 25218047
[TBL] [Abstract][Full Text] [Related]
16. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
17. Preparation, structural analysis, and properties of tenoxicam cocrystals.
Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
[TBL] [Abstract][Full Text] [Related]
18. An experimental and theoretical investigation of loperamide hydrochloride-glutaric acid cocrystals.
Bruni G; Maietta M; Maggi L; Mustarelli P; Ferrara C; Berbenni V; Freccero M; Scotti F; Milanese C; Girella A; Marini A
J Phys Chem B; 2013 Jul; 117(27):8113-21. PubMed ID: 23763498
[TBL] [Abstract][Full Text] [Related]
19. Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties.
Tsutsumi S; Iida M; Tada N; Kojima T; Ikeda Y; Moriwaki T; Higashi K; Moribe K; Yamamoto K
Int J Pharm; 2011 Dec; 421(2):230-6. PubMed ID: 21983091
[TBL] [Abstract][Full Text] [Related]
20. Crystal modifications and dissolution rate of piroxicam.
Lyn LY; Sze HW; Rajendran A; Adinarayana G; Dua K; Garg S
Acta Pharm; 2011 Dec; 61(4):391-402. PubMed ID: 22202198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
